Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma

Details

Language :

English

ISSN :

03666999 and 25425641

Volume :

134

Issue :

17

Database :

Supplemental Index

Journal :

Chinese Medical Journal (LWW)

Publication Type :

Periodical

Accession number :

ejs59578368

Full Text :

https://doi.org/10.1097/CM9.0000000000001511